Comprehensive Lung Care
Our experienced lung transplant team at Baylor University Medical Center, part of Baylor Scott & White Health includes coordinators, nurses, social workers, nutritionists, physical therapists, respiratory therapists, transplant pulmonologists, surgeons and anesthesiologists on the medical staff, who work together to provide quality outcomes for patients. We provide a rapid, comprehensive evaluation to determine the appropriateness and timing of transplantation.
Our goal is to see all patients referred for evaluation within seven days of referral. Transplant outcomes at Baylor Dallas are excellent and one year survival rates continue to improve despite increased severity of illness in patients. Waitlist times continue to decrease as transplant volumes steadily increase.
Not all patients with advanced lung disease are candidates for lung transplantation. The Baylor Dallas Advanced Lung Disease Program works closely with patients and referring physicians to offer advanced therapies for patients with complex lung diseases, even if they are not candidates for transplantation. Our program participates in clinical trials for new therapies to treat emphysema, interstitial lung disease and pulmonary hypertension.
Among the advanced treatments and clinical research provided are:
- Clinical trials in the treatment of usual interstitial pneumonia (pulmonary fibrosis)
- Minimally invasive lung volume reduction surgery (LVRS) for emphysema
- Extracorporeal membrane oxygenation (ECMO) for severe respiratory failure and adult respiratory distress syndrome (ARDS)